These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7560345)

  • 21. [Value of nucleolus organizer regions (AgNORs) in dermatologic oncology].
    Pfau A; Eckert F; Schröpfer T; Rüschoff J
    Hautarzt; 1994 Nov; 45(11):762-8. PubMed ID: 7822200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleolar organizer regions argyrophilic associated proteins in cutaneous melanocytic lesions.
    Reis JP; Tellechea O; Baptista AP
    Dermatologica; 1991; 183(2):136-8. PubMed ID: 1743375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.
    McNutt NS; Urmacher C; Hakimian J; Hoss DM; Lugo J
    J Cutan Pathol; 1995 Dec; 22(6):502-17. PubMed ID: 8835170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
    Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
    Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
    González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
    Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of silver binding nucleolar organizer regions (AgNORs) in proliferative lesions of bronchi, colon and thyroid--semiautomatic computer image analysis].
    Zaczek M
    Folia Med Cracov; 1996; 37(1-2):67-88. PubMed ID: 9312528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The nucleolus organizer region in benign and malignant melanocyte lesions of the skin: a quantitative study].
    Sementa AR; Gambini C; Borgiani L; Palladino M; Corso M; Canepa M
    Pathologica; 1989; 81(1073):231-7. PubMed ID: 2484303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferative activity in the malignant cellular blue nevus.
    Pich A; Chiusa L; Margaria E; Aloi F
    Hum Pathol; 1993 Dec; 24(12):1323-9. PubMed ID: 7903955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleolar organizer regions (NORs) in adenomyosis.
    Madej P; Plewka A; Madej JA; Plewka D; Rutkowski T
    Pathol Res Pract; 2006; 202(6):433-7. PubMed ID: 16513291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleolar organizer regions in Spitz nevi and malignant melanomas.
    Howat AJ; Giri DD; Cotton DW; Slater DN
    Cancer; 1989 Feb; 63(3):474-8. PubMed ID: 2912525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Quantitative evaluation of the nucleolus organizer regions (NORs) in malignant melanoma of the skin: is it a new prognosis index?].
    Gambini C; Sementa AR; Borgiani L; Massone L; Rovida S; Canepa M
    Pathologica; 1989; 81(1073):239-49. PubMed ID: 2641537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleolar organizer regions in determining malignancy of pigmented conjunctival lesions.
    Saornil MA; Marcus DM; Doepner D; Apolone G; Torre V; Albert DM
    Am J Ophthalmol; 1993 Jun; 115(6):800-5. PubMed ID: 8506916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
    Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
    Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of the AgNOR method for the differential diagnosis of tumors and for the quantification of non-neoplastic epidermal hyperproliferation in dermatohistology].
    Heinisch G; Barth J
    Zentralbl Pathol; 1994 Mar; 140(1):95-101. PubMed ID: 7515680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphologic clues and utility of fluorescence in situ hybridization for the diagnosis of nevoid melanoma.
    Yélamos O; Busam KJ; Lee C; Meldi Sholl L; Amin SM; Merkel EA; Obregon R; Guitart J; Gerami P
    J Cutan Pathol; 2015 Nov; 42(11):796-806. PubMed ID: 26356543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma.
    Lee JJ; Cook M; Mihm MC; Xu S; Zhan Q; Wang TJ; Murphy GF; Lian CG
    Oncotarget; 2015 Nov; 6(35):37995-8004. PubMed ID: 26462027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
    Orrell JM; Evans AT; Grant A
    J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manual and automated AgNOR count in differentiating reactive mesothelial from metastatic malignant cells in serous effusions.
    Mohanty SK; Dey P; Rana P
    Anal Quant Cytol Histol; 2003 Oct; 25(5):273-6. PubMed ID: 14603724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of nucleolar organizer regions and nuclear morphometry assessed by automatic image analysis in breast cancer with aneuploidy, K167 immunostaining, histopathologic grade and lymph node involvement.
    Charpin C; Bonnier P; Piana L; Kouzhami H; Devictor B; Lavaut MN; Andrac L; Allasia C
    Pathol Res Pract; 1992 Dec; 188(8):1009-17. PubMed ID: 1300597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silver-binding nucleolar organizer regions (AgNORs) in bronchial tumors.
    Zaczek M; Chłap Z; Szot W; Gil K; Hajduk A
    Folia Histochem Cytobiol; 1995; 33(2):83-8. PubMed ID: 8617383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.